Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levalbuterol vs Racemic Albuterol in Asthma
NCT00073840Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Dec 2002
- Primary completion
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levalbuterol in asthma (3 arms), sponsored by Sumitomo Pharma America. Primary endpoint: Forced Expiratory Volume in 1 Second (Peak Percent Change) at 8 weeks. Started Dec 2002; status: completed.
02
Drugs
levalbuterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00073840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073840.